Intuitive Surgical Shares Face Pressure Amid Growth Concerns

Intuitive Surgical US46120E6023

Despite posting impressive fourth-quarter 2025 results, Intuitive Surgical’s forward-looking guidance has unsettled investors. The stock has retreated significantly from recent highs, even as the company reported double-digit revenue growth and exceeded profit expectations. The market is now questioning whether the pioneer in robotic-assisted surgery is entering a period of sustained deceleration or if this is merely a healthy correction following a record run.

The company’s latest operational figures demonstrate its continued fundamental health. Intuitive Surgical delivered strong performance across several key metrics in Q4 2025:

• Revenue Growth: Sales climbed 19% year-over-year to $2.9 billion.
• Installed Base: The global number of da Vinci systems Read more...